Anti-coagulation Management Service (AQP 2nd Window)

Midlands & Lancashire CSU on behalf of Birmingham South Central CCG is seeking expressions of interest from suitably qualified providers for a Community Oral Anti-Coagulation service. The service is being commissioned using the Any Qualified Provider process.

The qualification period for this AQP accreditation will end on the 31st July 2017. The CCG may open up additional qualification rounds during the accreditation period. Should there be any geographical areas within the CCG area where further choice of provider is required; the CCG reserves the right to limit the next accreditation round to specific geographical areas only.

PLEASE NOTE THIS IS THE 2ND WINDOW – THE CCG IS ADVERTISING FOR THE PROVISION OF ANTI-COAGULATION SERVICES VIA AN AQP ARRANGEMENT FOR SET GEOGRAPHICAL LOCATIONS ONLY IN A BID TO IMPROVE SERVICE COVERAGE ACROSS THE CCG AREA. BIDS WILL ONLY BE ACCEPTED FROM PROVIDERS WHO WILL BE ABLE TO OFFER THE SERVICE WITHIN THE FOLLOWING POSTAL CODE AREAS (i.e.BIDS WILL BE ACCEPTED FOR SOME OR ALL THE FOLLOWING POST CODES ONLY):B48/Alvechurch

Service Description

Non-complex and appropriate stable complex patients aged 16 and over, registered to a GP practice in Birmingham South Central will access initiation, stabilisation, monitoring, dosing and prescribing anti-coagulant services, close to the patients home and accessible to all regardless of where they live or personal service ease-of-access need. Provide domiciliary visits to housebound patients.

The service will have equitable access, ensuring that patients are treated with dignity and respect, are fully informed about their care and are able to make decisions about their care in partnership with healthcare professionals.

It is critical that the provider identifies and manages appropriately, patients with specific needs i.e. poor compliance, housebound patients, unstable INR control, or frequent non attendees.

The service must optimise care to patients receiving anti-coagulant therapy in terms of accessibility, continuity and waiting times, and must offer patient choice of provider and best treatment available.

The frequency and the number of monitoring appointments will be patient specific with the aim of becoming less frequent as the patient achieves and maintains therapeutic range.

All patients will receive education and information about their treatment and management in accordance with written procedures and clinical protocols, in order to make decisions about their care in partnership with healthcare professionals.

Please see attached advert for further details about this service.

Additional information: How to apply:

• i)Register on the portal at https://mlcsu.bravosolution.co.uk (registration and use of the website is free of charge).

ii)Once registered, express interest by:

• a)logging-in to the MLCSU eTendering portal,

b)selecting response to advert and PQQ,

• c)select Open Access PQQ,
• d)search for and access PQQ Community Oral Anti-Coagulation service AQP and view details,
• e)click on Express Interest link.

• iii)Once you have expressed interest, access the My PQQs page where you can download documentation & construct your reply as instructed.

If you require technical support in submitting your expression of interest, please contact the BravoSolution help-desk on 0800 368 4850 or e-mail help@bravosolution.co.uk.